D-amino acids and unnatural residues in peptides

Several compounds in the research peptide market contain residues that no ribosome makes: D-amino acids, alpha-aminoisobutyric acid, naphthylalanine, C-terminal amides. These are deliberate design choices, and they have consequences for stability, analysis and how a batch's identity can be confirmed. This note explains what the common non-natural elements are, why they are used, and what they mean for verification. All Alphex products are for laboratory and in-vitro research only.

The common modifications

• D-amino acids. The mirror image of the natural L form. Proteases evolved to cleave L-peptide bonds and generally cannot handle D-residues, so inserting one at a cleavage site dramatically slows enzymatic degradation. Ipamorelin contains D-2-naphthylalanine and D-phenylalanine; GHRP-2 and GHRP-6 contain D-residues too.
• Alpha-aminoisobutyric acid (Aib). A doubly methylated glycine. It is achiral, sterically constrained, strongly favours helical conformation, and blocks the approach of proteases. Aib appears at the N-terminus of Ipamorelin and at key positions in glucagon-family peptides including retatrutide, where it protects against dipeptidyl peptidase cleavage.
• Naphthylalanine (2-Nal). A bulkier aromatic than phenylalanine, used to increase receptor affinity and hydrophobic contact.
• C-terminal amidation. Replacing the terminal carboxylate with an amide removes a negative charge, mimics many natural bioactive peptides, and improves stability. Ipamorelin is C-terminally amidated.
• N-terminal acetylation. Caps the terminal amine; TB-500 is acetylated.
• Lipidation. A fatty acid appended to a lysine side chain; see lipidated peptides.

What they change

• Protease resistance. The main purpose. A peptide with D-residues and Aib survives conditions that would degrade an all-L sequence in minutes, which matters for assay design and for degradation controls: do not assume a proteolysis control behaves as it would for a natural peptide.
• Conformation. Aib and D-residues bias secondary structure, which is often the point in receptor-binding design.
• Hydrophobicity. Naphthylalanine and other bulky aromatics increase retention on reverse-phase HPLC and reduce water solubility. See the solubility guide.
• Synthesis cost. Non-natural amino acid building blocks cost more than standard ones, and some couple less efficiently, which raises both price and the impurity burden. See how peptide pricing works.

The verification problem

D-amino acids weigh exactly the same as their L counterparts. Mass spectrometry therefore cannot distinguish the intended peptide from a stereochemically wrong one, and neither can amino acid analysis after standard hydrolysis. What does distinguish them:

• HPLC against a reference standard. Diastereomers usually resolve on reverse-phase columns; matching the standard's retention time is the practical stereochemical check. See reference standards.
• Chiral analysis (chiral GC or LC after hydrolysis with derivatisation) where certainty is required.
• Synthesis provenance. The building blocks used are what determine the stereochemistry; a competent manufacturer's process controls it.

So for a peptide such as Ipamorelin, a certificate showing HPLC purity, a retention match to the reference standard, and a correct mass together give a strong identity case; mass alone does not. See mass spectrometry explained and the Ipamorelin guide.

Racemisation as an impurity

Even in an all-L peptide, some racemisation occurs during synthesis, particularly at histidine and cysteine, producing diastereomeric impurities of identical mass. They appear as shoulders or nearby peaks on a good chromatogram, which is another reason to read the trace rather than the number. See common peptide impurities.

Alphex research peptides are supplied for laboratory and in-vitro research by qualified researchers only. They are not authorised for human or veterinary use.

Research use only. Alphex products are supplied exclusively for laboratory and in-vitro research by qualified researchers. They are not authorised for human or veterinary use, and nothing in this note is advice on any such use.

Published 13 February 2026. Alphex reviews research notes when the testing method, the catalogue or UK guidance changes.

Alphex Research Team

Alphex Limited, UK research peptide supplier

The Alphex research team writes and maintains these notes for UK laboratories buying research peptides. Every batch Alphex lists is verified by reverse-phase HPLC with a batch-matched Certificate of Analysis. Content covers laboratory and in-vitro research only.